MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-19-0001625
Bioviser Pharma Consulting Private Limited - business outsourcing in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹37.32 Lakh
▼ 43% YoY
Net profit · FY 2025
₹3.91 Lakh
Net margin 10.5%
EBITDA · FY 2025
₹5.56 Lakh
EBITDA margin 14.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
2
of 3 registered
About Bioviser Pharma Consulting Private Limited
Data last updated:
Bioviser Pharma Consulting Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the business and IT consulting segment of the business process outsourcing sector. It was incorporated on 10 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85310MH2019PTC329217. Its GSTIN is 27AAICB5917G1ZL (Maharashtra). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Santhosh Sirupa and Ivan Jissan Dsouza.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No 8 Bldg No 2 Shalom Chs Ltd Amboli Andheri West, Mumbai, Maharashtra, India – 400058.
As per the financials filed for FY 2025, the company reported a revenue of ₹37.32 Lakh, a decline of 43% compared to the previous year. For the same year it recorded a net profit of ₹3.91 Lakh (net margin 10.5%) and EBITDA of ₹5.56 Lakh (EBITDA margin 14.9%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 87% over five years.
The company is associated with 1 brand: Bioviser.
Bioviser Pharma Consulting Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0001625). For more details, the company can be reached via its website bioviser.com.
Company details
CIN U85310MH2019PTC329217
Registration Number 329217
Incorporation Date 10 August 2019
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0001625
Recognitions & Rankings of Bioviser Pharma Consulting
Contact details
Bioviser Pharma Consulting Private Limited's registered office is in Mumbai, Maharashtra. Its website is bioviser.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressFlat No 8 Bldg No 2 Shalom Chs Ltd Amboli Andheri West, Mumbai, Maharashtra, India – 400058
- IndustryBusiness Outsourcing, Business & IT Consulting
To see the full contact details of Bioviser Pharma Consulting Private Limited, buy the company report.
Comprehensive company report
Bioviser Pharma Consulting Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Bioviser Pharma Consulting operates one associated brand: Bioviser. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides consulting for pharmaceutical services, real-world evidence, and regulatory affairs. | bioviser.com |
Business activity
The main business activity of Bioviser Pharma Consulting is professional, scientific and technical activities. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, scientific and technical activities | 74 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Bioviser Pharma Consulting Private Limited, buy the company report.
Financials of Bioviser Pharma Consulting Private Limited
FY 2025 filings availableBioviser Pharma Consulting Private Limited reported revenue of ₹37.32 Lakh (down 43% YoY) for FY 2025.
Revenue · FY 2025
₹37.32 Lakh ▼ 43%
Net profit · FY 2025
₹3.91 Lakh margin 10.5%
EBITDA · FY 2025
₹5.56 Lakh margin 14.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 43%
3 years · compounded
▼ 20%
5 years · compounded
▲ 87%
EBITDA CAGR growth
1 year
▲ 145%
3 years · compounded
▲ 15%
5 years · compounded
▲ 18%
Revenue fell 43% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 87%. EBITDA rose 145% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.56 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.91 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.9% | ||||
| Net Profit Margin | 10.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bioviser Pharma Consulting Private Limited, buy the company report.
Board of directors of Bioviser Pharma Consulting Private Limited
Bioviser Pharma Consulting has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santhosh Sirupa | Director | 10 Aug 2019 | 7 Years 2 Months | Current |
| Ivan Jissan Dsouza Also directs: Iwana Consultancy Solutions Private Limited | Director | 10 Aug 2019 | 7 Years 2 Months | Current |
Auditor
Bioviser Pharma Consulting Private Limited is audited by Bikkina & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Bikkina & Associates | FY 2023 | 219074 |
Shareholding
The shareholding of Bioviser Pharma Consulting Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Bioviser Pharma Consulting Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Bioviser Pharma Consulting Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bioviser Pharma Consulting Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bioviser Pharma Consulting has 3 GST registrations: 2 active and 1 cancelled or inactive.
Total GSTINs
3
Active
2
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICB5917G1ZL | Maharashtra | Active | 17 Oct 2019 |
| 36AAICB5917G1ZM | Telangana | Active | 02 Feb 2020 |
To see the full GST registrations and return filing status of Bioviser Pharma Consulting Private Limited, buy the company report.
Recent activity
Bioviser Pharma Consulting Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Narayana Murthy Yalla ceased to be Director on 26 Feb 2021.
AGM
Bioviser Pharma Consulting Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Bioviser Pharma Consulting Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Narayana Murthy Yalla ceased to be Director.
Appointed
Ivan Jissan Dsouza was appointed as Director.
Appointed
Santhosh Sirupa was appointed as Director.
Incorporation
10 Aug 2019
Bioviser Pharma Consulting Private Limited was registered on 10 Aug 2019 with Roc Mumbai I & aged 7 years 2 months as per MCA records.
Frequently asked questions
Bioviser Pharma Consulting is an active private limited company based in Mumbai, Maharashtra, India. The company works in business and IT consulting, within the business outsourcing industry. It was incorporated on 10 August 2019 (7+ years old) and is registered under CIN U85310MH2019PTC329217.
Bioviser Pharma Consulting has 2 current directors:
- Santhosh Sirupa - Director
- Ivan Jissan Dsouza - Director
The latest financial statements of Bioviser Pharma Consulting on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Bioviser Pharma Consulting is 27AAICB5917G1ZL, registered in Maharashtra. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 36AAICB5917G1ZM (Telangana).
The CIN (Corporate Identification Number) of Bioviser Pharma Consulting is U85310MH2019PTC329217. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bioviser Pharma Consulting was incorporated on 10 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
Narayana Murthy Yalla ceased to be Director on 26 Feb 2021. Ivan Jissan Dsouza was appointed as Director on 10 Aug 2019. Santhosh Sirupa was appointed as Director on 10 Aug 2019.
Yes, Bioviser Pharma Consulting is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0001625).
Bioviser Pharma Consulting can be reached through the website bioviser.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Bioviser Pharma Consulting is at Flat No 8 Bldg No 2 Shalom Chs Ltd Amboli Andheri West, Mumbai, Maharashtra, India – 400058.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages